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Comparison of Effectiveness of Different Antiplatelet Doses of Aspirin in Patients
with Acute Coronary Syndrome
Haci Ali Kürklü, Çagdas¸ Özdöl, Türkan Seda Tan Kürklü, Aydan Ongun, Çetin Erol
Ankara University Medical Faculty, Ankara
Aım: Aspirin is an inhibitor of platelet function and is one of the cornerstones of acute
coronary syndrome (ACS) treatment. However, the ideal dose and usage of aspirin in
patients with ACS is not clear. The aim of this study is to investigate the antiplatelet
effects of different aspirin doses and application ways in patients with ACS.
Method: This study included 30 patients that were admitted to Cardiology Clinic of
Ankara University Faculty of Medicine with a diagnosis of acute coronary syndrome.
The patients included in the study were divided into three groups based on the dose of
aspirin utilization (1x100 mg, 1x300 mg, and 3x100 mg). On 3rd day of acute
coronary syndrome, thrombocyte aggregation levels, which were assesed by Ver-
ifyNow aspirin test, were compared at 2 hours (early) and 24 hours (late) after initial
aspirin.
Results: Ten of the patients (33%) were women and 20 were men (67%) and mean
age was 61.211.5 years. According to demographic and laboratory characteristics,
no statistical difference was determined between the groups. Antiplatelet effect of
aspirin at 2nd hour were as follows respectively; 402.429.3 ARU in aspirin 300mg
per day group, 440.436.7 ARU in 100mg 3 times a day group and 418.241 ARU
in aspirin 100 mg per day group (p¼0.04). All groups’ ARU values were increased at
24th hour compared with ﬁrst 2nd hour measurements but this increase was minimum
in 3x100 mg aspirin group. There were no difference in ARU values at 24th hour
measurement between groups. No aspirin resistance observed in any of the patients.
Conclusıon: Antiplatelet effect of both 100 mg and 300 mg aspirin doses decreased
during the day but their efﬁcacy still continued and no difference was detected
between the doses. Despite the theoretical advantages of the use of aspirin in divided
doses, our study did not support this.
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2nd hour
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ARU
402,429,3 440,436,7 418,241 0,04
24th hour
VerifyNow
ARU
432,329 453,945,7 452,445,2 0,45 Table 1
Variable Group 1(n¼26) Group 2 (n¼ 79) p
Age (years) 54.0  10.2 61.3  9.4 <0.01
Male gender (%) 7 (26.9) 49 (62.0) <0.01
BMI (kg/m2) 29.9  4.0 29.5  5.2 0.73
Waist circumference (cm) 99.5  9.5 104.7  9.9 0.11
Current smoker (%) 6 (23.1) 21 (26.6) 0.72
Hypertension (%) 11 (42.3) 32 (40.5) 0.91
Diabetes mellitus (%) 5 (19.2) 20 (25.3) 0.57
Dyslipidemia (%) 4 (15.4) 15 (19.0) 0.74
WBC (x103/mL) 7.2  1.4 7.5  1.9 0.42
Neutrophil count (x103/mL) 3.9  1.0 4.4  1.2 0.11
Neutrophil/Lymphocyte Ratio 1.7  0.4 2.0  0.8 0.04
Vessel score 0 0.8  1.1 (0–3) <0.01
Gensini score 0 44.2  58.5 (1–204) <0.01
SYNTAX score 0 11.7  6.6 (2–26) <0.01
NGAL (pg/mL) 6.0  1.3 11.9  3.3 <0.01
Patient demographics and clinical characteristics.PP-287
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Implication of Serum Neutrophil Gelatinase-Associated Lipocalin Levels in
Patients Who Underwent First-time Diagnostic Coronary Angiography
Ahmet Bacaksız1, Ziya Ismailoglu1, Ahu Sarbay2, Sitki Kucukbuzcu1, Seref Kul1,
Abdurrahman Tasal1, Osman Sonmez1, Ercan Erdogan1, Murat Turfan1,
Mehmet Akif Vatankulu1, Parviz Jafarov1, Mehmet Ergelen1, Omer Goktekin1
1Bezmi Âlem Foundation University, Faculty of Medicine, Department of Cardiology,
Istanbul, 2University of lstanbul, Cerrahpasa Medical Faculty, Department of
Biochemistry, Istanbul
Purpose: Atherosclerosis is a chronic inﬂammatory process and systemic inﬂamma-
tion plays key role in each step from endothelial dysfunction, formation of athero-
matous plaques, to clinical presentation as symptomatic coronary artery disease
(CAD) due to plaque rupture and formation of occlusive thrombus. Neutrophil
gelatinase-associated lipocalin (NGAL) is a protein secreted by activated neutrophils
which recently demonstrated as a diagnostic marker of CAD. The aim of this study is
to investigate clinical relevance of circulating NGAL levels in patents who underwent
coronary angiography with suspected CAD.
Methods: One hundred and ﬁve consecutive patients (49 females, 56 males; mean age
59.7 years) who underwent ﬁrst-time diagnostic coronary angiography from March
2013 to June 2013 were included in this study. Peripheral blood samples were taken
from antecubital vein for determination of hemogram and serum NGAL concentra-
tions before coronary angiography. Patients with impaired renal function and elevated
white blood cell counts were excluded. The severity and extent of CAD was evaluated
by calculation of vessel and Gensini scores. Also, SYNTAX score was calculated in
patients with 50% stenosis. Results were reported as mean  standard deviation and
percentages. Continuous variables were analyzed using the Student's t-test. A value of
p < 0.05 was considered statistically signiﬁcant.C196 JACC VoResults: Demographic and clinical characteristics of the patients were listed in Table
1. Patients with CAD (group 2) were signiﬁcantly older compared to patients without
CAD (group 1) and the number of male patients were signiﬁcantly higher in group 2
(p<0.05). Although white blood cell and polymorphonuclear neutrophil counts were
not different in both groups, neutrophil to lymphocyte ratio (NLR) was signiﬁcantly
elevated in group 2 (p¼0.04). Serum NGAL levels in patients with CAD were
signiﬁcantly higher than those in patients without CAD (11.9  3.3 vs 6.0  1.3 pg/
mL; p<0.01). The NGAL levels were correlated with NLR, the number of diseased
vessels and Gensini score but not with the SYNTAX score (Figure 1). The diagnostic
value for serum NGAL in discriminating patients without CAD from those with CAD
was high (AUC¼0.975). If we used as cutoff for serum NGAL 7.5 pg/mL, we could
predict presence of CAD with sensitivity and speciﬁty, 92.3% and 97.5%,
respectively.
Conclusıons: We demonstrated that serum levels of NGAL as a biomarker of
neutrophil activation are higher in patients with CAD than in patients without CAD. It
could be used to discriminate patients with CAD before diagnostic coronary angi-
ography. Also, it was positively and signiﬁcantly correlated with severity and extent of
CAD.PP-289
Is Metabolic Syndrome Related with Coronary Artery Disease Severity and
Complexity: An Observational Study About IDF And AHA/NHLBI Metabolic
Syndrome Deﬁnitions?
Ahmet Çagrı Aykan, _Ilker Gül, Ezgi Kalaycıoglu, Tayyar Gökdeniz, Engin Hatem,
Ümit Mentes¸e
Ahi Evren Chest Cardiovascular Surgery Education and Research Hospital, Trabzon
Background: The aim of the present study was to assess the association between
metabolic syndrome (MS) and coronary artery disease (CAD) complexity assessed by
SYNTAX score (SS) and severity in non-diabetic patients with stable CAD whom
underwent coronary angiography and to evaluate whether the MS deﬁned by different
deﬁnitions including International Diabetes Federation (IDF) and (American Heartl 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
Association/National Heart Lung Blood Institute) AHA/NHLBI guidelines similarly
correlated with SS.
Methods: The present study is cross sectional and observational with prospective
inclusion of 248 consecutive patients (157 male) who underwent coronary angiog-
raphy due to stable coronary artery disease.
Results: Basal patient characteristics are shown in Table-1. The prevalence of MS was
54.4% according to IDF deﬁnition and 50.4% according to AHA/NHLBI deﬁnition.
MS score according to IDF deﬁnitions (r¼0.446, p<0.001), MS score according to
AHA/NHLBI deﬁnitions (r¼0.341, p<0.001) were moderately correlated with SS. In
Fisher r to z transformation test the correlations of the presence of MS according to
IDF and AHA/NHLBI deﬁnitions with SS was not statistically signiﬁcant (p¼0.168,
z¼-1.38). The systolic blood pressure (p<0.001, B¼0.354, CI95%¼-0.308-0.228),
diastolic blood pressure (p¼0.006, B¼-0.194, CI95%¼-0.333- -0.056), age (p¼0.014,
B¼0.147, CI95%¼0.029-0.264), left ventricular ejection fraction (p¼0.031, B¼-
0.150, CI95%¼-0.286- -0.014), waist/hip circumference (p<0.001, B¼45.713,
CI95%¼23.235-68.1919) and log10 high density lipoprotein (p<0.001, B¼-22.209,
CI95%¼-33.298- -11.119) were the independent predictors of SS in linear regression
analysis.
Conclusıon: Metabolic syndrome is associated with the presence and complexity of
CAD. Besides the presence of discrepancy about the limits of waist circumference,
both IDF and AHA/NHLBI criteria were similarly correlated with CAD complexity.Table-1
Variable
MS IDF
MS(-) (113) p
MS AHA/
NHLBI
MS(-)(123) p
MS(+) (135) MS(+)(125)
Age, year 60.619.66 61.359.15 0.544 60.609.35 61.309.51 0.559
Male, n(%) 90(66.7%) 67(59.3%) 0.230 81(64.8%) 76(61.8%) 0.623
HT, n(%) 87(64.4%) 45(39.8%) <0.001 80(64.0%) 52(42.3%) 0.001
HL, n(%) 52(38.5%) 32(28.3%) 0.091 47(37.6%) 37(30.1%) 0.211
Smoking,
n(%)
55(40.7%) 40(35.4%) 0.389 50(40%) 45(36.6%) 0.580
BMI kg/m2 29.263.49 25.844.45 <0.001 29.363.61 26.024.31 <0.001
WC,cm 95.7612.11 81.3012.72 <0.001 95.9412.52 82.2912.70 <0.001
HC,cm 99.687.41 94.807.11 <0.001 99.847.60 95.046.96 <0.001
WC/HC ratio 0.960.10 0.860.10 <0.001 0.960.11 0.860.10 <0.001
Triglyceride,
mg/dl
188(126) 111(43) <0.001 191(124) 111(48) <0.001
HDL, mg/dl 39(12) 50(14.5) <0.001 38(13) 48(14) <0.001
Glucose,
mg/dl
104(18) 94.5(12.5) <0.001 105(19) 95(13) <0.001
LDL, mg/dl 149.0339.71 136.4536.65 0.011 149.6340.17 136.8736.36 0.009
TC, mg/dl 211.8740.06 204.2340.63 0.171 212.8347.05 203.8839.80 0.107
Creatinine,
mg/dl
0.840.20 0.850.21 0.648 0.830.20 0.860.21 0.421
eGFR, ml/
min/
1.73m2
108.6232.26 92.7932.32 <0.001 108.8631.88 93.8232.87 <0.001
SBP, mmHg 146.2412.58 137.6016.57 <0.001 146.1812.75 138.3616.34 <0.001
DBP, mmHg 88.5610.32 83.399.39 <0.001 88.3110.60 84.079.39 0.001
PP, mmHg 57.6711.64 54.2010.82 0.016 57.8711.83 54.2810.66 0.013
MAP, mmHg 107.799.68 101.4711.14 <0.001 107.609.90 102.1711.07 <0.001
MS score 3.790.76 1.420.64 <0.001 3.610.73 1.440.63 <0.001
LV EF, % 63.488.80 62.417.18 0.299 64.067.64 61.908.43 0.035
LVMI
mg/m2
117.7636.19 116.4841.05 0.794 117.6836.26 116.6640.62 0.836
SYNTAX
score
10.50(20.5) 0(3) <0.001 10(20.25) 0(5) <0.001
Table 1
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Mean Platelet Volume is Associated with Poor Post-Interventional Myocardial
Blush Grade in Patients with ST Segment Elevation Myocardial Infarction
Bahadır S¸arlı1, Ahmet O Baktır1, Hayrettin Saglam1, Hüseyin Arınç1, Serkan Kurtul1,
Mahmut Akpek2, Mehmet G Kaya2
1Department of Cardiology, Kayseri Education and Research Hospital, Kayseri,
2Department of Cardiology, Erciyes University School of Medicine, Kayseri
Objectıve: In a signiﬁcant proportion of patients with ST elevation myocardial
infarction (STEMI), microvascular and myocardial reperfusion can not be regained in
spite of successfully restored Thrombolysis In Myocardial Infarction (TIMI) grade 3JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTepicardial blood ﬂow. Myocardial blush grade (MBG) is a reliable marker for
microvascular patency and predicts short and long term mortality after primary PCI in
patients with acute STEMI, independently of other variables. Mean platelet volume
(MPV), a unique measure of platelet size, is an indicator of platelet reactivity. In
this study, we aimed to investigate the relation of admission MPV with post-
interventional MBG in patients with STEMI and TIMI grade 3 ﬂow at infarct artery
after primary PCI.
Methods: Three hundred and ten patients were selected as study group among patients
with STEMI and TIMI grade 3 epicardial blood ﬂow after primary PCI. Blood
samples for analysis were obtained during initial evaluation of patients at emergency
department. Myocardial blush grade of patients were classiﬁed at the end of angio-
plasty. Patients with MBG 0 and 1 were deﬁned as having poor myocardial blush and
patients with MBG 2 and 3 were deﬁned as having well myocardial blush.
Results: Patients with poor myocardial blush had higher admission MPV (10.51.3
fL to 9.11fL, p<0.001), higher peak creatine kinase myocardial band isoensyme
levels (26053 U/L to 19038 U/L, p<0.001), higher white blood cell (WBC) count
(11.34x103/ml to 10.33x103 /ml, p¼0.012) and lower left ventricular ejection
fraction (LVEF) (427% to 518%, p<0.001) compared to patients with well
myocardial blush. Linear regression analysis showed that admission MPV was
signiﬁcantly associated with post-interventional MBG (coefﬁcient¼0.598, p<0.001).
Cardiovascular mortality (13% to 5%, p¼0.013) and acute-subacute stent thrombosis
at 3 months (12% to 8%, p¼0.028) were signiﬁcantly higher in patients with poor
post-interventional myocardial blush compared to those with well myocardial blush.
Conclusıon: Mean platelet volume measured at admission is signiﬁcantly associated
with poor post-interventional MBG in patients with STEMI and TIMI grade 3 ﬂow at
infarct artery after primary PCI.ERS C197
